FindTrial
Sign In

A Phase III Study of P-4 to Investigate Overactive Bladder

A Phase III Study of P-4 to Investigate Overactive Bladder

Status
Unknown
Phases
Phase 3
Study type
Interventional
Source
JPRN
Registry ID
JPRN-jRCT2080220467
Enrollment
Unknown
Registered
2007-11-14
Start date
2007-11-14
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Overactive bladder

Interventions

investigational material(s) Generic name etc : P-4 (Propiverine hydrochloride) INN of investigational material : propiverine Therapeutic category code : 259 Other agents for uro-genital and anal organ

Sponsors

Taiho Pharmaceutical Co., Ltd.
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Patients with overactive bladder symptoms

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Efficacy and safety—

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026